CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRLNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CRL. That does not mean none is planned.
Get an email about CRL's next catalysts
Track CHARLES RIVER LABORATORIES INTERNATIONAL (CRL) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
How CRL's past catalysts played out
Market Overview
Stock performance and key metrics
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
WebsiteNo drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CRL biotech catalysts?→
Add CRL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.